The Role of Multiparametric MRI and MRI-targeted Biopsy in Detecting Clinically Significant Prostate Cancer in the Community Setting: A Retrospective Study

Kenneth E Schmanke; Jordan J Stiverson; Rosalee E Zackula; Serge G Srour; Matthew P Lierz; Fadi N Joudi

The Role of Multiparametric MRI and MRI-targeted Biopsy in Detecting Clinically Significant Prostate Cancer in the Community Setting: A Retrospective Study

Rev Urol. 2020;22(2):57-66.

Authors

Kenneth E Schmanke¹, Jordan J Stiverson¹, Rosalee E Zackula¹, Serge G Srour², Matthew P Lierz¹, Fadi N Joudi³

Affiliations

¹ University of Kansas School of Medicine-Wichita Wichita, KS.
² Department of Diagnostic Radiology, University of Kansas School of Medicine-Wichita Wichita, KS.
³ Wichita Urology Group Wichita, KS.

PMID: 32760229
PMCID: PMC7393688

Abstract

Multiparametric MRI and the Prostate Imaging-Reporting and Data System (PI-RADS) have emerged as tools to reveal suspicious prostate lesions and MRI-targeted biopsy has shown potential to avoid repeat prostate biopsies and miss fewer significant cancers. This retrospective study sought to assess the differences in diagnostic yield and sampling efficiency between MRI-targeted and standard biopsies in a community urology practice. We concluded that MRI-targeted biopsy was more efficient than a standard biopsy, although neither technique achieved a superior diagnostic yield of clinically significant cancer in our community setting. We recommend that a standard biopsy be performed alongside targeted biopsy.

Keywords: Ambulatory care facilities; Health services research; Image-guided biopsy; Multiparametric MRI; Prostatic neoplasms.